[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca].
In lack of professional research and appropriate concepts our scientific knowledge of psychedelic agents is limited. According to the long-held official view these drugs are entirely harmful and have no medical use. However, a recent surge of clinical and pharmacological studies in the field indicates that many psychedelic-like agents have therapeutic potentials under proper circumstances. In this paper, from a biomedical and psychological perspective, we provide a brief review of the general effects and promising treatment uses of medical cannabis, 3,4-methylenedioxy-methamphetamine (MDMA), salvinorin A, ibogaine and the dimethyltryptamine-(DMT)-containing ayahuasca. In Hungary - similarly to many other countries - these compounds are classified as "narcotic drugs" and their research is difficult due to strict regulations.
Immunológiai Intézet, Debreceni Egyetem, Debrecen, Hungary. efrecska@hotmail.com.
Attila
A
Szabó
Anita
A
Kazai
Ede
E
Frecska
Zoltán
Z
Brys
D031581:Banisteriopsis; D061891:Controlled Substances; D045785:Diterpenes, Clerodane / Q000494:pharmacology*; D006213:Hallucinogens / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006814:Hungary; D007050:Ibogaine / Q000494:pharmacology*; D064086:Medical Marijuana / Q000494:pharmacology*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology*; D008517:Phytotherapy / Q000379:methods; D027544:Salvia; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation
D061891:Controlled Substances; D045785:Diterpenes, Clerodane; D006213:Hallucinogens; D064086:Medical Marijuana; D007050:Ibogaine; D018817:N-Methyl-3,4-methylenedioxyamphetamine; C090499:salvinorin A